𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa-induced dyskinesia: clinical observations

✍ Scribed by Andrzej Friedman

Publisher
Springer
Year
1985
Tongue
English
Weight
315 KB
Volume
232
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Levodopa-induced dyskinesia
Levodopa-induced dyskinesia
✍ Agid Yves πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 93 KB
Levodopa-induced dyskinesias
Levodopa-induced dyskinesias
✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do

Nondopaminergic mechanisms in levodopa-i
Nondopaminergic mechanisms in levodopa-induced dyskinesia
✍ Jonathan M. Brotchie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

## Abstract It has become increasingly apparent that Parkinson's disease involves many transmitter systems other than dopamine. This nondopaminergic involvement impacts on the generation of symptoms, on the neurodegenerative process, but, most tellingly, in the generation of side effects of current

Molecular mechanisms underlying levodopa
Molecular mechanisms underlying levodopa-induced dyskinesia
✍ Paolo Calabresi; Massimiliano Di Filippo; Veronica Ghiglieri; Barbara Picconi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 521 KB

Although levodopa remains the most effective drug for the symptomatic treatment of Parkinson's disease, chronic therapy with this pharmacological compound initiates a complex cascade of cellular and molecular downstream effects resulting in the development of abnormal involuntary movements. The prec